Harvard Bioscience Inc
NASDAQ:HBIO
Harvard Bioscience Inc
EPS (Diluted)
Harvard Bioscience Inc
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Harvard Bioscience Inc
NASDAQ:HBIO
|
EPS (Diluted)
$0
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-58%
|
CAGR 10-Years
-21%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
EPS (Diluted)
$15
|
CAGR 3-Years
-8%
|
CAGR 5-Years
15%
|
CAGR 10-Years
16%
|
|
Danaher Corp
NYSE:DHR
|
EPS (Diluted)
$10
|
CAGR 3-Years
20%
|
CAGR 5-Years
26%
|
CAGR 10-Years
12%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
EPS (Diluted)
$36
|
CAGR 3-Years
9%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
|
Agilent Technologies Inc
NYSE:A
|
EPS (Diluted)
$4
|
CAGR 3-Years
17%
|
CAGR 5-Years
3%
|
CAGR 10-Years
7%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
EPS (Diluted)
$7
|
CAGR 3-Years
52%
|
CAGR 5-Years
43%
|
CAGR 10-Years
14%
|
See Also
What is Harvard Bioscience Inc's EPS (Diluted)?
EPS (Diluted)
-0.2
USD
Based on the financial report for Mar 31, 2024, Harvard Bioscience Inc's EPS (Diluted) amounts to -0.2 USD.
What is Harvard Bioscience Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
-21%
Over the last year, the EPS (Diluted) growth was -300%. The average annual EPS (Diluted) growth rates for Harvard Bioscience Inc have been -22% over the past three years , -58% over the past five years , and -21% over the past ten years .